Patients with premature cardiovascular disease and a positive family history for cardiovascular disease are prone to recurrent events

被引:15
|
作者
Mulders, Ties A. [2 ,3 ,4 ]
Meyer, Zainna [2 ]
van der Donk, Christel [2 ]
Kroon, Abraham A. [2 ,4 ]
Ferreira, Isabel [2 ,5 ]
Stehouwer, Coen D. A. [2 ,4 ]
Pinto-Sietsma, Sara-Joan [1 ,3 ]
机构
[1] Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1100 DD Amsterdam, Netherlands
[2] Univ Med Ctr Maastricht, Dept Internal Med, Div Gen Internal Med, Subdiv Vasc Med, Maastricht, Netherlands
[3] Acad Med Ctr, Dept Internal Med, Div Vasc Med, NL-1100 DD Amsterdam, Netherlands
[4] Univ Med Ctr Maastricht, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands
[5] Univ Med Ctr Maastricht, Dept Clin Epidemiol & Med Technol Assessment KEMT, Maastricht, Netherlands
关键词
Premature cardiovascular disease; Positive family history; CORONARY-HEART-DISEASE; FACTOR-V-LEIDEN; MYOCARDIAL-INFARCTION; RISK; SUSCEPTIBILITY; SMOKING; PROTEIN;
D O I
10.1016/j.ijcard.2010.08.040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Premature cardiovascular disease (CVD) is treated in the same way as CVD of advanced age. However, in patients with premature CVD and a family history of CVD, different -possibly genetic-mechanisms may underlie this disease, which current medical treatment is not targeted to. This suggests that subjects with a genetic predisposition to CVD are more likely to have recurrent cardiovascular events. Methods: We retrospectively investigated 291 patients with premature CVD and assessed the amount of recurrent events according to family history in a follow-up period of 31 years. Premature CVD was defined as an event <51 years for men or <56 for women. We used a Cox proportional hazards model to estimate the relationship between a positive family history and recurrence of cardiovascular events. Results: Patients with recurrent events had more often a positive family history (60.0% vs. 47.1%; p<0.05), were more often smokers (85.2% vs. 70.7%; p<0.05), had more often hypertension (36.3% vs. 23.6%; p<0.05) and had a longer follow-up period (10.0 years vs. 5.4 years; p<0.001) than patients without recurrent events. After adjusting for these differences and modelling time to events, a positive family history was independently associated with recurrent events (Hazard ratio 1.31 (95% confidence intervals (CI) 1.01-1.72; p<0.05)). Conclusions: Patients with a genetic predisposition for CVD are at risk for recurrent events, after adjusting for risk factors and other confounders. This might imply that in subjects with a genetic predisposition for CVD different pathophysiological mechanisms are active, leading to recurrent events. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:64 / 67
页数:4
相关论文
共 50 条
  • [31] Retinal vascular function in asymptomatic individuals with a positive family history of cardiovascular disease
    Seshadri, Swathi
    Karimzad, Said E.
    Shokr, Hala
    Gherghel, Doina
    [J]. ACTA OPHTHALMOLOGICA, 2018, 96 (08) : E956 - E962
  • [32] LIPOPROTEIN(A) AND FAMILY HISTORY OF CARDIOVASCULAR DISEASE IN CHILDREN
    Guardamagna, O.
    Abello, F.
    Assandro, P.
    Anfossi, G.
    Pirro, M.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 21 - 21
  • [33] FAMILY HISTORY SCREENING FOR PREMATURE CARDIOVASCULAR DISEASE AND HYPERCHOLESTEROLAEMIA IN NEWBORNS: AN ECONOMIC, SUSTAINABLE AND FAST STRATEGY TO IDENTIFY HIGH CARDIOVASCULAR DISEASE RISK SUBJECTS
    Capra, M. E.
    Biasucci, G.
    Banderali, G.
    Pederiva, C.
    [J]. ATHEROSCLEROSIS, 2023, 379 : S89 - S90
  • [34] Aspirin for Primary Cardiovascular Prevention in Patients with Family History of Cardiovascular Disease: Meta-analysis
    Antunes, Miguel M.
    Alves, Mariana
    Ferreira, Joaquim J.
    Pinto, Fausto J.
    Caldeira, Daniel
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2021, 35 (04) : 871 - 873
  • [35] Aspirin for Primary Cardiovascular Prevention in Patients with Family History of Cardiovascular Disease: Meta-analysis
    Miguel M. Antunes
    Mariana Alves
    Joaquim J. Ferreira
    Fausto J. Pinto
    Daniel Caldeira
    [J]. Cardiovascular Drugs and Therapy, 2021, 35 : 871 - 873
  • [36] Cardiovascular Disease in Childhood, Adolescent, and Young Adult Cancer Survivors: The Impact of Family History of Premature Heart Disease
    Berkman, Amy M.
    Andersen, Clark R.
    Landstrom, Andrew P.
    Hildebrandt, Michelle A. T.
    Gilchrist, Susan C.
    Roth, Michael E.
    [J]. JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 2024, 13 (03) : 548 - 556
  • [37] Are there ethnic differences in the association between family history of cardiovascular disease and prevalent cardiovascular disease in the UK?
    Baker, J.
    Mitchell, R.
    Pell, J.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 125 - 125
  • [38] PREMATURE CARDIOVASCULAR-DISEASE
    HOYT, CS
    [J]. MINNESOTA MEDICINE, 1977, 60 (10) : 749 - 749
  • [39] FAMILY HISTORY OF CARDIOVASCULAR DISEASE IN YOUNG PATIENTS WITH ACUTE CORONARY SYNDROME
    Averkova, A. O.
    Brazhnik, V. A.
    Rogozhina, A. A.
    Evdokimova, M. A.
    Koroleva, O. S.
    Sizgunov, D. S.
    Zubova, E. A.
    Karmanchikova, E. A.
    Galyavich, A. S.
    Hasanov, N. R.
    Ivantsov, E. N.
    Magamedkerimova, F. A.
    Chichkov, Y. M.
    Chichkova, M. A.
    Kovalenko, N., V
    Tereshenko, S. N.
    Minushkina, L. O.
    Koziolova, N. A.
    Glezer, M. G.
    Boyeva, O., I
    Horolets, E., V
    Konstantinov, V. O.
    Zateyshchikov, D. A.
    [J]. KARDIOLOGIYA, 2018, 58 (08) : 12 - 17
  • [40] Multifocal cardiovascular calcification in patients with established cardiovascular disease; prevalence, risk factors, and relation with recurrent cardiovascular disease
    van 't Klooster, Cilie C.
    Nathoe, Hendrik M.
    Hjortnaes, J.
    Bots, Michiel L.
    Isgum, Ivana
    Lessmann, Nikolas
    van der Graaf, Yolanda
    Leiner, Tim
    Visseren, Frank L. J.
    [J]. IJC HEART & VASCULATURE, 2020, 27